Welcome to our dedicated page for Transact Tech SEC filings (Ticker: TACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransAct Technologies Inc. (NASDAQ: TACT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. TransAct files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K covering financial results, material agreements and other significant corporate events.
Recent 8-K filings describe preliminary quarterly financial results, including net sales, gross profit, operating income or loss, net income or loss, EBITDA and adjusted EBITDA, as well as FST recurring revenue and casino and gaming net sales. These filings often attach press releases as exhibits and explain the company’s use of non-GAAP measures such as EBITDA and adjusted EBITDA, including why management and lenders consider them useful in evaluating operating performance.
Other 8-Ks detail material definitive agreements, such as the Source Code Purchase and Perpetual License Agreement with Avery Dennison for BOHA™ source code and a Third Amendment to the company’s headquarters lease in Hamden, Connecticut. These documents outline key terms, payment milestones, license rights and lease modifications that can affect TransAct’s operations and cost structure.
Through Stock Titan, users can follow TransAct’s real-time filing activity as new documents are posted to EDGAR, and then use AI-powered tools to summarize and interpret lengthy reports. This includes quickly understanding the main points in 10-K and 10-Q filings, reviewing 8-K disclosures about earnings releases and agreements, and examining exhibits related to technology licensing or facilities. The filings page is a resource for investors who want to analyze TransAct’s financial reporting, risk disclosures and contractual commitments directly from its official SEC submissions.
TransAct Technologies CEO John Dillon exercised previously granted Restricted Stock Units that vested under the company’s 2014 Equity Incentive Plan, converting 8,675 RSUs into the same number of common shares at a price of $0.00 per share.
After these derivative exercises and conversions on February 28, March 1, and March 2, Dillon directly owned 167,218 shares of common stock.
TransAct Technologies President and CFO Steven A. DeMartino reported multiple equity-award vesting events and related tax withholdings in late February and early March. On March 1, 2026, Performance Stock Units granted on March 1, 2023 converted into 7,629 shares of common stock, with some shares withheld to cover taxes. Restricted Stock Units granted in 2022, 2023 and 2024 also vested and converted one-for-one into common shares on February 28, March 1, and March 2, 2026. Several Form 4 entries coded “F” show shares delivered back to the company at prices around $3.46–$3.50 solely to satisfy tax or exercise obligations, rather than open-market sales, leaving DeMartino with a remaining direct holding of common stock.
TransAct Technologies Chief Marketing Officer Dana Loof reported an equity award of 14,124 Restricted Stock Units on February 25, 2026. These RSUs were granted under the company’s 2014 Equity Incentive Plan, vest in a single “cliff” tranche on the second anniversary of the grant, and then convert into common stock on a one-for-one basis.
TransAct Technologies reported that Chief Accounting Officer William DeFrances received a grant of 6,780 Restricted Stock Units on February 25, 2026. These RSUs were issued under the company’s 2014 Equity Incentive Plan, as Amended and Restated.
The award cliff vests on the second anniversary of the grant date and then converts into common stock on a one-for-one basis, aligning the executive’s compensation with future company performance. Following these transactions, his directly held common stock balance is reported as zero shares.
TransAct Technologies Chief Technology Officer Brent Richtsmeier reported an equity compensation grant. On February 25, 2026, he acquired 14,124 Restricted Stock Units under the company’s 2014 Equity Incentive Plan, as Amended and Restated. These RSUs vest 25% each year, starting on the first anniversary of the grant date.
Following this filing, his directly held common stock position is 21,695 shares, and his RSU holdings total 14,124 units, reflecting his long-term, equity-based compensation alignment with the company.
DILLON JOHN reported acquisition or exercise transactions in this Form 4 filing.
TRANSACT TECHNOLOGIES INC CEO John Dillon reported an equity award of 55,862 Restricted Stock Units on February 25, 2026. These RSUs were granted under the company’s 2014 Equity Incentive Plan, as Amended and Restated, and vest 25% each year starting on the first anniversary of the grant date.
Following this award, Dillon holds 55,862 Restricted Stock Units directly and 158,543 shares of common stock in direct ownership, aligning a significant portion of his compensation with the company’s future performance.
TransAct Technologies Inc Chief Revenue Officer Tracey S. Chernay received a grant of 14,124 Restricted Stock Units on February 25, 2026. The units were issued at no cash cost under the company’s 2014 Equity Incentive Plan, as Amended and Restated.
The RSUs cliff vest on the second anniversary of the grant date and then convert into common stock on a one-for-one basis. Following the grant, Chernay directly holds 14,124 RSUs and no shares of common stock are listed as directly owned after this transaction.
TransAct Technologies CEO John Dillon reported awards and vesting of performance-based equity. On February 24, 2026, he was granted 177,320 Performance Stock Units (PSUs) at no cost under the company’s 2014 Equity Incentive Plan. The PSUs were originally issued on May 1, 2025 and vest in three equal installments on February 24, 2026, 2027, and 2028.
On the same date, 59,106 PSUs were exercised and converted into 59,106 shares of common stock on a one-for-one basis, also at no cost. These PSUs were earned based on 2025 Revenue and Adjusted EBITDA performance, with a payout level of 155%. After these transactions, Dillon directly held 158,543 shares of common stock and 118,213 PSUs.
TransAct Technologies President and CFO Steven A. DeMartino reported equity award activity involving performance stock units (PSUs) and common stock. He received a grant of 62,620 PSUs at no cost and exercised 20,873 PSUs that converted into an equal number of common shares on a one-for-one basis. Following these transactions, he directly held 177,929 shares of common stock and 41,747 PSUs. A separate disposition of 7,082 common shares at $3.49 per share was made to cover tax liabilities related to the award, rather than an open-market sale. The PSUs were issued under the company’s 2014 Equity Incentive Plan and vest in three equal installments on February 24, 2026, February 24, 2027, and February 24, 2028, with the final payout level based on 2025 revenue and adjusted EBITDA performance at a 155% achievement level.
TransAct Technologies Chief Technology Officer Brent Richstmeier reported equity compensation activity tied to 2025 performance. On February 24, 2026, he received a grant of 39,215 Performance Stock Units (PSUs) that vest in three equal installments on February 24, 2026, 2027 and 2028. On the same date, 13,072 PSUs previously issued on May 1, 2025 converted into an equal number of common shares, reflecting a 155% payout based on 2025 revenue and Adjusted EBITDA results. To cover taxes related to this vesting, 3,879 common shares were disposed of at $3.49 per share, leaving Richstmeier with 21,695 common shares directly owned after these transactions.